Pramlintide, as an adjunct to basal insulin, reduced C-reactive protein, improved glycemic control, and led to weight loss in patients with type 2 diabetes

被引：0

|

作者：

Lush, Cameron

Frias, Juan

Zhang, Bei

Maier, Holly

Kolterman, Orville

机构：

来源：

DIABETES | 2007年 / 56卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A144 / A144

页数：1

相关论文

共 50 条

[1] Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin
Riddle, Matthew
Frias, Juan
Zhang, Bei
Maier, Holly
Brown, Carl
Lutz, Karen
Kolterman, Orville
[J]. DIABETES CARE, 2007, 30 (11) : 2794 - 2799
[2] Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes treating to target with basal insulin
Riddle, Matthew
Zhang, Bei
Maier, Holly
Wilhelm, Ken
Kolterman, Orville
[J]. DIABETES, 2008, 57 : A156 - A156
[3] Pramlintide improved glycemic control and reduced body weight in patients with type 2 diabetes treated with basal insulin (without mealtime insulin) and a thiazolidinedione
Lorenzi, Gayle
Frias, Juan
Lutz, Karen
Kesty, Nicole
Zhang, Bei
Kolterman, Orville
[J]. DIABETES, 2007, 56 : A147 - A147
[4] Pramlintide improved glycaemic control and reduced weight in patients with type 2 diabetes treating to target with basal insulin
Wilhelm, K.
Riddle, M.
Zhang, B.
Maier, H.
Kolterman, O.
[J]. DIABETOLOGIA, 2008, 51 : S409 - S409
[5] Pramlintide as adjunctive treatment to insulin in type 2 diabetes resulted in improved glycemic control and concomitant weight loss
Maggs, DG
Burrell, TA
Fineman, MS
Kolterman, OG
[J]. DIABETES, 2001, 50 : A124 - A125
[6] Pramlintide, as an adjunct to insulin therapy, led to improved control of both glycemia and weight in African American and Hispanic patients with type 2 diabetes
Kolterman, O
Maggs, D
Burrell, T
Strobel, S
Brown, D
Weyer, C
[J]. DIABETES, 2003, 52 : A124 - A125
[7] Pramlintide, as an adjunct to long-acting insulin, led to improved A1C and body weight in patients with type 2 diabetes
Lush, Cameron
Strobel, Susan
Zhang, Bei
Frias, Juan
[J]. DIABETES, 2006, 55 : A124 - A124
[8] Pramlintide as an adjunct to insulin glargine reduced A1C and body weight in patients with type 2 diabetes
Frias, Juan
Bei, Zhang
Darsow, Tamara
[J]. DIABETES, 2006, 55 : A112 - A112
[9] Pramlintide, as an adjunct to premixed insulin, reduced A1C and body weight in patients with type 2 diabetes
Lorenzi, Gayle
Zhang, Bei
Darsow, Tamara
Maier, Holly
Wilhelm, Ken
[J]. DIABETES, 2008, 57 : A585 - A585
[10] Pramlintide as an adjunct to insulin therapy improved glycemic and weight control in people with type 2 diabetes during treatment for 52 weeks
Fineman, M
Gottlieb, A
Skare, S
Kolterman, O
[J]. DIABETES, 2000, 49 : A106 - A106

← 1 2 3 4 5 →